Thursday, 18th November 2021
13:30 |
Test Run and Web Checks
|
14:30 |
Welcome Address and Introduction to the Experts
Sanjay Bajaj, CEO & MD, Glostem Private Limited, India
|
14:50 |
Select Emerging Requirements w.r.t Method Validation
Saranjit Singh, Ex-Professor & Head, Pharmaceutical Analysis, NIPER, Mohali, India
|
15:10 |
Open Discussion/ QA Session
|
15:15 |
Significance of Implementing QbD in Analytical Method Development – A Case Study Overview
Trupti Tol, Associate Director - QbD-IPD, Cipla Ltd, India |  |
|
15:30 |
Open Discussion/ QA Session
|
15:40 |
Analytical Procedure Lifecycle
Bhaskar Kolte, Associate Director - Analytical Research Development, Perrigo, India
|
15:55 |
Open Discussion/ QA Session
|
16:05 |
Reference Standard Qualification
Chait Wannere, Senior Director, Analytical Development, TCG GreenChem, USA
|
16:20 |
Open Discussion/ QA Session
|
16:35 |
AMQ, AMV, APT Studies for Analytical Platform Technology (APT) Methods
Stephan O. Krause, Head of Product Quality Group, AstraZeneca Biologics, USA
|
17:00 |
Open Discussion/ QA Session
|
17:15 |
Rap Session
|
17:30 |
Closing Remarks (Prof Saranjit Singh)
|
17:35 |
Vote of Thanks (Dr Sanjay Bajaj)
|
